PILL vs. XTJL
PILL (Direxion Daily Pharmaceutical & Medical Bull 3X Shares) and XTJL (Innovator U.S. Equity Accelerated Plus ETF - July) are both Leveraged Equities funds. PILL is passively managed, while XTJL is actively managed. Over the past 3 years, PILL returned 16.40%/yr vs 14.67%/yr for XTJL. A 0.58 correlation means they provide meaningful diversification when combined. PILL charges 0.98%/yr vs 0.79%/yr for XTJL.
Performance
PILL vs. XTJL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PILL achieves a -1.69% return, which is significantly lower than XTJL's 5.38% return.
PILL
- 1D
- 8.24%
- 1M
- -11.70%
- YTD
- -1.69%
- 6M
- 7.86%
- 1Y
- 123.35%
- 3Y*
- 16.40%
- 5Y*
- -10.52%
- 10Y*
- —
XTJL
- 1D
- 0.02%
- 1M
- 1.01%
- YTD
- 5.38%
- 6M
- 6.35%
- 1Y
- 15.58%
- 3Y*
- 14.67%
- 5Y*
- —
- 10Y*
- —
PILL vs. XTJL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares | -1.69% | 75.14% | -7.26% | -12.06% | -43.16% | -36.15% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 5.38% | 15.42% | 14.43% | 25.72% | -15.66% | 7.28% |
Correlation
The correlation between PILL and XTJL is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.45 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Jul 2, 2021 | 0.58 |
The correlation between PILL and XTJL shifts across timeframes, from 0.45 (1 year) to 0.58 (all time), reflecting how their relationship changes across market environments.
PILL vs. XTJL - Sectors Allocation Comparison
Sectors
PILL
XTJL
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
PILL
XTJL
Basic Materials
PILL
-
XTJL
Communication Services
PILL
-
XTJL
Consumer Cyclical
PILL
-
XTJL
Consumer Defensive
PILL
-
XTJL
Energy
PILL
-
XTJL
Financial Services
PILL
-
XTJL
Industrials
PILL
-
XTJL
Real Estate
PILL
-
XTJL
Technology
PILL
-
XTJL
Utilities
PILL
-
XTJL
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PILL vs. XTJL — Risk / Return Rank
PILL
XTJL
PILL vs. XTJL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PILL | XTJL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.62 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.46 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 3.74 | 3.06 | +0.68 |
| Martin ratioReturn relative to average drawdown | 12.24 | 17.30 | -5.06 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PILL | XTJL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.99 | 2.11 | -0.12 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.17 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.11 | 0.65 | -0.75 |
Drawdowns
PILL vs. XTJL - Drawdown Comparison
The maximum PILL drawdown since its inception was -88.76%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for PILL and XTJL.
Loading charts...
Drawdown Indicators
| PILL | XTJL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.76% | -23.24% | -65.52% |
Max Drawdown (1Y)Largest decline over 1 year | -33.21% | -5.12% | -28.09% |
Max Drawdown (3Y)Largest decline over 3 years | -60.43% | -16.70% | -43.73% |
Max Drawdown (5Y)Largest decline over 5 years | -83.38% | — | — |
Current DrawdownCurrent decline from peak | -66.31% | 0.00% | -66.31% |
Average DrawdownAverage peak-to-trough decline | -58.54% | -4.04% | -54.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.12% | 0.90% | +9.22% |
Volatility
PILL vs. XTJL - Volatility Comparison
Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) has a higher volatility of 22.02% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 0.31%. This indicates that PILL's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PILL | XTJL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.02% | 0.31% | +21.71% |
Volatility (6M)Calculated over the trailing 6-month period | 48.70% | 5.72% | +42.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 62.21% | 7.42% | +54.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.53% | 15.21% | +45.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.83% | 15.21% | +48.62% |
PILL vs. XTJL - Expense Ratio Comparison
PILL has a 0.98% expense ratio, which is higher than XTJL's 0.79% expense ratio.
Dividends
PILL vs. XTJL - Dividend Comparison
PILL's dividend yield for the trailing twelve months is around 0.64%, while XTJL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares | 0.64% | 0.69% | 1.28% | 1.83% | 0.67% | 0.00% | 0.00% | 0.38% | 0.91% | 0.10% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
PILL and XTJL have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PILL has higher volatility (22.02%) compared to XTJL (0.31%). In terms of maximum drawdown, PILL dropped -88.76% vs XTJL's -23.24%.
On 3-year performance, PILL leads with 16.40% vs 14.67% for XTJL. On fees, XTJL is cheaper at 0.79% per year. On volatility, XTJL has been the lower-risk option at 0.31%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, PILL has performed better with a 16.40% return vs 14.67%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XTJL is cheaper with a 0.79% expense ratio, compared with 0.98% for PILL.
PILL has the higher dividend yield at 0.64%, compared with 0.00% for XTJL.
They also come from different issuers: Direxion and Innovator. Their fees differ too: 0.98% for PILL and 0.79% for XTJL.
XTJL currently has the higher Sharpe Ratio (2.11 vs 1.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PILL and XTJL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer